Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.60 USD
Change Today +0.0499 / 1.96%
Volume 1.3K
VSCP On Other Exchanges
As of 8:10 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

virtualscopics inc (VSCP) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/8/14 - $5.15
52 Week Low
07/21/15 - $2.26
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VIRTUALSCOPICS INC (VSCP)

Related News

No related news articles were found.

virtualscopics inc (VSCP) Related Businessweek News

No Related Businessweek News Found

virtualscopics inc (VSCP) Details

VirtualScopics, Inc. provides imaging solutions to the pharmaceutical, biotechnology, and medical device industries. The company offers a suite of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its proprietary software and algorithms provide measurement capabilities designed to improve clinical research and development. The company’s image-based measurement and visualization tools enable automated, accurate, and reproducible measurement of minute changes that occur in anatomic structures in musculoskeletal, oncological, cardiological, and neurological diseases. It has strategic alliances with PPD, Inc. to provide clients with an integrated and customized clinical development and medical imaging solution for oncology clinical trials; and IXICO, plc. to provide imaging contract research services related to clinical trials of drugs and medical devices across a range of therapeutic areas and modalities. VirtualScopics, Inc. was founded in 2000 and is headquartered in Rochester, New York.

85 Employees
Last Reported Date: 03/31/15
Founded in 2000

virtualscopics inc (VSCP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $385.0K
Chief Financial Officer
Total Annual Compensation: $175.2K
Compensation as of Fiscal Year 2014.

virtualscopics inc (VSCP) Key Developments

VirtualScopics and IXICO Alliance Receive Contracts in Oncology and Neurodegenerative Disease

VirtualScopics Inc. along with IXICO plc announced that the alliance has been awarded contracts with two top 15 pharmaceutical companies, one in metastatic solid tumors and one in a rare neurodegenerative disease. IXICO's TrialTracker™ digital platform will be deployed in both studies to collect and manage imaging data and in the neurodegeneration study, IXICO's Assessa® digital technology will be used to analyze MRI data collected from patients. The metastatic solid tumor study will make use of VirtualScopics extensive expertise applying FDG-PET (Fludeoxyglucose PET) to measuring disease progression in oncology and will involve working with imaging centers across North America and Europe. The study is expected to complete in June 2017. The neurodegeneration study will make use of IXICO's expertise in structural MRI and will involve IXICO working with key opinion leaders across specialist imaging centers throughout North America. As part of this contract, IXICO's Assessa® medical device will utilize its proprietary LEAP methodology to quantify disease pathology in brain regions that are particularly relevant to measuring disease progression and will be applied to MRI data collected from subjects enrolled in the study. The study is expected to complete in January 2018.

VirtualScopics Inc. - Shareholder/Analyst Call

2015 annual meeting of shareholders

VirtualScopics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2015

VirtualScopics Inc. reported earnings results for the first quarter ended March 31, 2015. Revenues for the first quarter of 2015 rose 20% to $2,814,442 compared to revenues of $2,352,986 for the prior year period. The company reported a net loss for the first quarter of 2015 of $552,670, or $0.20 per share, representing a 14% improvement from a net loss of $646,373, or $0.23 per share, reported in the first quarter of 2014. The 20% increase in revenue during the first quarter of 2015 is the result of the company's strong performance in awards and bookings in 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSCP:US $2.60 USD +0.0499

VSCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ICON PLC $75.20 USD +10.25
PAREXEL International Corp $68.40 USD +1.70
PRA Health Sciences Inc $41.74 USD +1.13
View Industry Companies

Industry Analysis


Industry Average

Valuation VSCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIRTUALSCOPICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at